Bio

Bio


Ani is a nurse practitioner with previous experience in clinical research in cardiovascular disease. Her clinical practice is providing pre and post operative medical care for the admitted vascular surgery patients, and ensuring discharge plans are seamless and comprehensive. She has been a nurse practitioner for the inpatient Vascular Surgery service since 2014 and was promoted to the Lead Advanced Practice Provider in 2020. She oversees all aspects of the Vascular Surgery APP's in Palo Alto, Pleasanton, and Emeryville. She completed her master of science in nursing, and nurse practitioner training at the Yale School of Nursing in New Haven, CT; and remains an active alumni member. She is a board certified Adult-Gerontology Acute Care Nurse Practitioner.

Clinical Focus


  • Nurse Practitioner
  • Vascular Surgery

Honors & Awards


  • Yale School of Nursing Alumni Association Board Member, Yale

Education & Certifications


  • BS, UCSD, Biology (2007)
  • MPH, USC, Epidemiology & Biostatistics (2009)
  • MSN, Yale University, Adult- Gero Acute Care (2014)
  • Board Certification: American Nurses Credentialing Center, Nurse Practitioner (2014)

Publications

All Publications


  • Effectiveness and Safety of an Independently Run Nurse Practitioner Outpatient Cardioversion Program (2009 to 2014) AMERICAN JOURNAL OF CARDIOLOGY Norton, L., Tsiperfal, A., Cook, K., Bagdasarian, A., Varady, J., Shah, M., Wang, P. 2016; 118 (12): 1842-1846

    Abstract

    Sustained growth in the arrhythmia population at Stanford Health Care led to an independent nurse practitioner-run outpatient direct current cardioversion (DCCV) program in 2012. DCCVs performed by a medical doctor, a nurse practitioner under supervision, or nurse practitioners from 2009 to 2014 were compared for safety and efficacy. A retrospective review of the electronic medical records system (Epic) was performed on biodemographic data, cardiovascular risk factors, medication history, procedural data, and DCCV outcomes. A total of 869 DCCVs were performed on 557 outpatients. Subjects were largely men with an average age of 65 years; 1/3 were obese; most had atrial fibrillation; and majority of subjects were on warfarin. The success rate of the DCCVs was 93.4% (812 of 869) with no differences among the groups. There were no short-term complications: stroke, myocardial infarction, or death. The length of stay was shortest in the NP group compared to the other groups (p <0.001). In conclusion, the success rate of DCCV in all groups was extremely high, and there were no complications in any of the DCCV groups.

    View details for DOI 10.1016/j.amjcard.2016.08.074

    View details for Web of Science ID 000389868400011

    View details for PubMedID 27771002

Footer Links:

Home | Stanford Medicine

Latest information on COVID-19

Stanford Medicine is closely monitoring the COVID-19 pandemic. Get the latest news on COVID-19 testing, treatment, tracking data, and medical research.

Racism and discrimination are direct affronts to Stanford Medicine?s values. Read our leaders? pledge on racial equity.

A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.

Analyzing a national cancer database, Stanford Medicine researchers find a bump in diagnoses at 65, suggesting that many wait for Medicare to kick in before they seek care.

Our scientists have launched dozens of research projects as part of the global response to COVID-19. Some aim to prevent, diagnose and treat the disease; others aim to understand how it spreads and how people?s immune systems respond to it.

A Stanford Medicine team offered guidance in crafting a COVID-19 response for the Oglala Lakota Nation.

Medical students recently learned where they would be heading for their residencies.

Sharon Hampton is focusing on patient equity as a nursing leader at Stanford Health Care. Getting to know patients and staff is key, she says.

Stanford Medicine Resources: